We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIntercede Regulatory News (IGP)

Share Price Information for Intercede (IGP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 105.50
Bid: 103.00
Ask: 108.00
Change: -0.50 (-0.47%)
Spread: 5.00 (4.854%)
Open: 105.50
High: 105.00
Low: 105.00
Prev. Close: 105.50
IGP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Intercede Group Interim Results

29 Nov 2010 07:00

RNS Number : 9267W
Intercede Group PLC
29 November 2010
 



 

 

 

 

29 NOVEMBER 2010

 

 

INTERCEDE GROUP plc

('Intercede', 'the Company' or 'the Group')

 

Interim Results for the 6 Months Ended 30 September 2010

 

Intercede (AIM: IGP.L) is a leading producer of Identity and Credential Management software, called MyID, which manages the secure registration, issuance and life cycle of digital identities for a wide range of uses.

 

 

SUMMARY

 

- 25% increase in sales to £3,506,000 (2009: £2,811,000).

 

- Operating profit before exceptional items of £1,204,000 (2009: £674,000).

 

- Profit for the period of £1,225,000 (2009: £85,000).

 

- Basic and fully diluted earnings per share of 2.5p (2009: 0.2p).

 

- Cash generated from operations before exceptional items of £630,000 (2009: £762,000).

 

- Cash balances of £4,470,000 at 30 September 2010 (30 September 2009: £3,913,000).

 

- No external borrowings.

 

- Increased investment in international sales and technical capabilities to support growing demand for and use of Intercede's proprietary MyID Identity and Credential Management System.

 

- Continued expansion of Intercede's customer base in the US.

 

- Winning new contracts to supply MyID to government ministries, banks and business corporations around the world.

 

 

Richard Parris, Chairman & Chief Executive of Intercede, said today:

 

"We have made excellent progress this year, both commercially and financially. Intercede MyID is being used by an increasing base of new and existing customers and the pipeline of future orders is stronger than it has ever been. The Company is increasingly profitable, cash generative and financially strong.

 

"This year represents a tipping point in the evolution of Intercede's business and is indicative of the strong commercial progress we continue to make. We look forward to a favourable outcome for the current financial year and to achieving further growth thereafter."

 

 

Further Information on Intercede MyID

Intercede MyID is the only IDCMS software product that enables organisations to easily and securely manage the identities of people and their associated identity credentials within a single, integrated, workflow driven platform. This includes enabling and managing: secure registration, biometric capture, application vetting and approval through to smart card personalisation, issuance and management.

 

MyID was the first electronic personalisation product to achieve compliance with the FIPS-201 standard and is widely deployed by Federal Agencies, government contractors and other commercial entities. In particular, it supports the latest standards applicable for all PIV, PIV-Interoperable and PIV-Compatible deployments.

 

It can issue and manage a wide variety of ID's and credentials, providing customers with a platform that can meet their needs now and in the future. It is a fully supported commercial off-the-shelf product that can be quickly deployed for thousands or millions of users.

 

About Intercede

Intercede is the producer of the MyID Identity and Credential Management System (IDCMS).

 

Intercede MyID technology is being used around the world by large corporations, governments and banks to manage millions of identities for employees, citizens and customers. Notable deployments in the US include 14 Federal Agencies, 1.7m smart cards in support of the US Transportation Worker Identity Credential program, two major US financial institutions and 310,000 smart corporate identity badges for Lockheed Martin and another defense contractor. In Europe and the Middle East, Intercede MyID is being deployed in support of government identity, health and corporate employee ID security projects.

 

For more information visit http://www.intercede.com

 

 

 

ENQUIRIES

 

Intercede Group plc Tel. +44 (0)1455 558 111Richard Parris, Chairman & Chief ExecutiveAndrew Walker, Finance Director

 

FinnCap Tel. +44 (0)20 7600 1658Clive CarverSarah Wharry

 

Pelham Bell Pottinger Tel. +44 (0)20 7861 3112Archie BerensClare Gilbey

 

 

 

Chairman's Statement

 

Introduction

I am pleased to report that Intercede has made excellent progress in the six months ended 30 September 2010. Revenues have increased by 25% to £3,506,000 (2009: £2,811,000) and operating profits have increased from £95,000 to £1,204,000.

 

The cash balance as at 30 September 2010 was £4,470,000 compared to £3,913,000 at 30 September 2009 and £4,664,000 at 31 March 2010. As previously reported, the Group effectively entered the current financial year with a cash balance of £3,917,000 net of post year end exceptional payments relating to the previous financial year. As a result of strong orders received during the period, the cash balance has subsequently increased to in excess of £5,000,000 at 29 November 2010.

 

This year represents a tipping point in the evolution of Intercede's business and is indicative of the strong commercial progress we continue to make.

 

 

Commercial Progress

Major commercial progress made during the year to date includes:

 

• Large new US Federal Agency selects MyID for a PIV-Compatible solution.

 

• US manufacturing and defense systems company licenses MyID for the issuance of 160,000 PIV-Compatible cards.

 

• Sale of an additional 400,000 MyID licenses to BT for the NHS Data Spine project bringing the total licenses sold to date to 1,200,000.

 

• Securing additional orders totalling in excess of $1.0m for MyID software licenses, custom development and professional services in support of the internal identity badge programs at Lockheed Martin and the US Federal Aviation Authority.

 

• Supporting Lockheed Martin on the US Transportation Worker Identity Credential (TWIC) program which has to date issued 1.7 million cards to US dock workers using MyID.

 

• Supplying additional Intercede MyID licenses to Booz Allen Hamilton, a large US based global management consultancy group, in support of a PIV-Interoperable employee badging solution.

 

• The addition of a major Intergovernmental Organisation (IGO) to Intercede's customer list.

 

• Securing additional orders totalling more than € 250,000 from the Road Transportation and Vehicle Licensing Agencies in Ireland and the Netherlands.

 

• The sale of Intercede MyID licenses to an Australian government customer.

 

• The provision of additional services to the State of Kuwait in support of the National ID card project.

 

 

Financial Results

The financial results reflect the continued momentum from the Group's involvement in an increasing number of projects around the world. Sales increased by 25% to £3,506,000 (2009: £2,811,000) which resulted in an increase in operating profit from £95,000 to £1,204,000. There was also a substantial increase in operating profit before exceptional items from £674,000 to £1,204,000.

 

Staff costs continue to represent the main area of expense totalling approximately 81% of the total operating costs during the period. The average number of employees and contractors increased from 54 to 56 year on year.

 

A profit for the period of £1,225,000 (2009: £85,000) resulted in a basic and fully diluted earnings per share of 2.5p (2009: 0.2p). The adjusted fully diluted earnings per share, based upon profit prior to tax and exceptional item of £1,225,000 (2009: £664,000) is 2.5p (2009: 1.4p).

 

The cash balance as at 30 September 2010 was £4,470,000 compared to £3,913,000 at 30 September 2009 and £4,664,000 at 31 March 2010. As previously reported, the Group effectively entered the current financial year with a cash balance of £3,917,000 net of post year end exceptional payments relating to the previous financial year. Therefore, the Group has generated £630,000 of cash from operations before exceptional items during the six month period (2009: £762,000).

 

Outlook

The first half of the year has been profitable and cash generative. As in previous years, the full year outcome will be dependent upon the timing of receipt of orders and our subsequent ability to deliver and recognise revenues in accordance with the Group's accounting policy. Nevertheless, the level and pace of customer and partner activity is greater than in previous periods and the sales pipeline is stronger than ever. We therefore remain confident that our operating performance will continue to meet expectations.

 

 

 

Richard Parris

Chairman & Chief Executive

29 November 2010

 

 

 

 

Consolidated Statement of Comprehensive Income

For the period ended 30 September 2010

 

 

 

6 Months ended

30 September 2010

£'000

6 Months ended

30 September 2009

£'000

Year ended

31 March 2010

£'000

 

Continuing operations

 

 

 

Revenue

3,506

2,811

6,194

Cost of sales

(8)

(73)

(66)

 

_________

_________

_________

 

 

 

 

Gross profit

3,498

2,738

6,128

Administrative expenses

(2,294)

(2,643)

(5,619)

 

_________

_________

_________

Operating profit

1,204

95

509

 

 

 

 

Operating profit before exceptional item

1,204

674

2,026

Exceptional item

-

(579)

(1,517)

 

_________

_________

_________

Operating profit

1,204

95

509

 

 

 

 

Finance income

21

16

27

Finance costs

-

(26)

(26)

 

_________

_________

_________

Profit before tax

1,225

85

510

Taxation

-

-

(14)

 

_________

_________

_________

Profit for the period

1,255

85

496

 

_____

_____

_____

Total comprehensive income attributable to owners of the company

 

1,225

 

85

 

496

 

_____

_____

_____

Earnings per share (pence)

- basic

 

2.5p

 

0.2p

 

1.1p

- diluted

2.5p

0.2p

1.0p

_____

_____

_____

 

Consolidated Balance Sheet

As at 30 September 2010

 

 

 

As at

30 September 2010

£'000

As at

30 September 2009

£'000

As at

31 March 2010

£'000

 

 

 

 

Non-current assets

 

 

 

Property, plant and equipment

152

70

84

Deferred tax

280

280

280

 

_________

_________

_________

 

432

350

364

 

_________

_________

_________

 

 

 

 

Current assets

 

 

 

Trade and other receivables

1,867

687

954

Cash and cash equivalents

4,470

3,913

4,664

 

_________

_________

_________

 

6,337

4,600

5,618

 

_________

_________

_________

 

 

 

 

Total assets

6,769

4,950

5,982

 

_____

_____

_____

 

 

 

 

Equity

 

 

 

Called up share capital

4,413

4,413

4,413

Share premium account

4,718

4,718

4,718

Other reserves

1,508

1,508

1,508

Retained earnings

(6,272)

(7,908)

(7,497)

 

_________

_________

_________

Total equity

4,367

2,731

3,142

 

_________

_________

_________

 

 

 

 

Current Liabilities

 

 

 

Trade and other payables

773

1,025

1,385

Deferred revenue

1,629

1,194

1,455

 

_________

_________

_________

 

2,402

2,219

2,840

 

_________

_________

_________

 

 

 

 

Total equity and liabilities

6,769

4,950

5,982

 

_____

_____

_____

 

 

Consolidated Statement of Changes in Equity

As at 30 September 2010

 

 

 

Share

capital

£'000

Share

premium

£'000

Other

reserves

£'000

Equity

reserve

£'000

Retained

earnings

£'000

Total

 

£'000

 

 

 

 

 

 

 

At 31 March 2010

4,413

4,718

1,508

-

(7,497)

3,142

Total comprehensive income

-

-

-

-

1,225

1,225

 

______

______

______

______

______

______

At 30 September 2010

4,413

4,718

1,508

-

(6,272)

4,367

 

___

___

___

___

___

___

 

 

 

 

 

 

 

 

 

 

 

 

 

 

At 31 March 2009

4,305

2,875

1,508

109

(8,102)

695

Issue of shares, net of costs

108

1,843

-

(109)

109

1,951

Total comprehensive income

-

-

-

-

85

85

 

______

______

______

______

______

______

 

4,413

4,718

1,508

-

(7,908)

2,731

 

___

___

___

___

___

___

 

 

 

 

 

 

 

 

At 31 March 2009

4,305

2,875

1,508

109

(8,102)

695

Issue of shares, net of costs

108

1,843

-

(109)

109

1,951

Total comprehensive income

-

-

-

-

496

496

 

______

______

______

______

______

______

At 31 March 2010

4,413

4,718

1,508

-

(7,497)

3,142

___

___

___

___

___

___

 

 

Consolidated Cash Flow Statement

For the period ended 30 September 2010

 

 

 

 

 

As at

30 September 2010

£'000

As at

30 September 2009

£'000

As at

31 March 2010

£'000

 

 

 

 

 

 

Cash flows from operating activities

 

 

 

 

Operating profit

1,204

95

509

 

Exceptional item

-

579

1,517

 

 

_________

_________

_________

 

Operating profit before exceptional item

1,204

674

2,026

 

Depreciation

21

15

31

 

(Increase) / decrease in trade and other receivables

 

(904)

 

214

 

(60)

 

Increase / (decrease) in trade and other payables

 

309

 

(141)

 

88

 

 

_________

_________

_________

 

Cash generated from operations before exceptional item

 

630

 

762

 

2,085

 

Exceptional item

(747)

(549)

(1,085)

 

Taxation

-

-

(14)

 

 

_________

_________

_________

 

Net cash (used by) / generated from operating activities

 

(117)

 

213

 

986

 

 

_________

_________

_________

 

 

 

 

 

 

 

 

 

 

 

Investing activities

 

 

 

 

Interest received

12

18

25

 

Purchases of property, plant and equipment

 

(89)

 

(19)

 

(48)

 

 

_________

_________

_________

 

Net cash used by investing activites

(77)

(1)

(23)

 

 

_________

_________

_________

 

 

 

 

 

 

 

 

 

 

 

Financing activities

 

 

 

 

Costs on issue of shares

-

(10)

(10)

 

 

_________

_________

_________

 

 

 

 

 

 

 

 

 

 

 

Net (decrease) / increase in cash and cash equivalents

 

(194)

 

202

 

953

 

Cash and cash equivalents at the beginning of the period

 

4,664

 

3,711

 

3,711

 

 

_________

_________

_________

 

Cash and cash equivalents at the end of the period

 

4,470

 

3,913

 

4,664

 

 

_____

_____

_____

 

 

 

 

 

 

 

 

Notes to the Accounts

For the period ended 30 September 2010

 

1 Preparation of the interim financial statements

These interim financial statements have been prepared under IFRS as adopted by the European Union and on the basis of the accounting policies set out in the Group's Annual Report for the year ended 31 March 2010.

 

The Group is not required to apply IAS 34 Interim Financial Reporting at this time.

 

These interim financial statements have not been audited and do not constitute statutory accounts as defined in Section 434 of the Companies Act 2006. Statutory accounts for the year ended 31 March 2010 have been delivered to the Registrar of Companies. The Auditors' Report on those accounts was unqualified and did not contain any statement under Section 498 (2) or (3) of the Companies Act 2006.

 

The Interim Report will be mailed to shareholders prior to the end of December 2010 and copies will be available on the website (www.intercede.com) and at the registered office: Intercede Group plc, Lutterworth Hall, St Mary's Road, Lutterworth, Leicestershire, LE17 4PS.

 

 

2 Revenue

All of the Group's revenue, operating profits and net assets originate from operations in the United Kingdom. The Directors consider that the activities of the Group constitute a single business segment.

 

The split of revenue by geographical destination of the end customer can be analysed as follows:

 

 

 

6 months ended

6 months ended

Year ended

 

30 September 2010

30 September 2009

31 March 2010

 

£'000

£'000

£'000

 

 

 

 

United Kingdom

838

795

1,601

Rest of Europe

351

806

1,389

USA

2,032

1,085

2,795

Rest of World

285

125

409

 

__________

__________

__________

 

3,506

2,811

6,194

 

__________

__________

__________

 

 

 

 

 

 

3 Exceptional item

The exceptional item represents the costs associated with defending a patent infringement lawsuit which was filed by ActivIdentity in the United States District Court for the Northern District of California on 1 October 2008. No further legal costs are expected to arise following the settlement of this claim on 23 March 2010.

 

 

4 Taxation

There is no charge for corporation tax due to the availability of losses brought forward from prior years.

 

 

5 Earnings per share

The calculations of earnings per ordinary share are based on the profit and the weighted average number of ordinary shares in issue during each period.

 

 

 

6 months ended

6 months ended

Year ended

 

30 September 2010

30 September 2009

31 March 2010

 

 

 

 

Profit for the period

1,225

85

496

Adjusted profit before tax and exceptional item

1,225

664

2,027

 

__________

__________

__________

 

 

 

 

 

Number

Number

Number

Weighted average number of shares

- basic

48,178,005

44,704,340

46,304,420

- diluted

48,735,005

48,735,005

48,735,005

 

__________

__________

__________

 

 

 

 

 

Pence

Pence

Pence

Earnings per share - basic

2.5p

0.2p

1.1p

- diluted

2.5p

0.2p

1.0p

- adjusted*

2.5p

1.4p

4.2p

 

__________

__________

__________

 

* Adjusted fully diluted earnings per share based on profit before tax and exceptional item.

 

 

6 Dividend

The Directors do not recommend the payment of a dividend.

 

 

7 Capital Reduction

On 2 November 2010, the Registrar of Companies issued the certificate of registration of a court order for the reduction of share capital of the Company and the cancellation of its share premium account. The reduction of capital was approved by shareholders at the Company's AGM held on 24 September 2010.

 

The effect of the capital reduction is to eliminate the deficit showing as profit and loss account reserves, thereby facilitating the payment of a dividend as and when the Board considers this to be appropriate.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR BFBPTMBMTBLM
Date   Source Headline
26th Apr 202410:02 amRNSShare Incentive Scheme
23rd Apr 20247:00 amRNSCapital Markets Day
8th Apr 20247:00 amRNSTrading Update
2nd Apr 20247:00 amRNSContract and Subscription Renewals
25th Mar 20243:38 pmRNSHolding(s) in Company
25th Mar 20243:35 pmRNSHolding(s) in Company
22nd Mar 20247:00 amRNSNew Orders and Trading Update
21st Mar 20247:00 amRNSNew Product Announcement: Launch of MyID MFA v5
6th Feb 20247:00 amRNSDirector/PDMR Shareholding
29th Jan 20247:00 amRNSNew Orders
18th Jan 20249:55 amRNSDirector/PDMR Shareholding
3rd Jan 20247:00 amRNSMajor New Contract Win
7th Dec 20237:00 amRNSUpdate on Major New Contract Win
5th Dec 202312:30 pmRNSMajor New Contract with Large US Federal Agency
22nd Nov 20237:00 amRNSDirector/PDMR Shareholding
21st Nov 20237:01 amRNSNew Contract and Renewal Orders
21st Nov 20237:00 amRNSHalf-year Report
7th Nov 20237:00 amRNSContract and Renewals Orders
25th Oct 20234:44 pmRNSDirector/PDMR Shareholding
24th Oct 20237:00 amRNSNotice of Interim Results & Investor Presentation
20th Oct 20237:03 amRNSAppointment of Non-Executive Director
11th Oct 20237:00 amRNSDirector/PDMR Shareholding
10th Oct 20237:00 amRNSTrading Update
21st Sep 20231:31 pmRNSResult of AGM
4th Sep 20237:00 amRNSContract and Renewals Orders
30th Aug 20237:10 amRNSNotice of AGM and Publication of Annual Report
20th Jun 20237:01 amRNSBoard Changes
20th Jun 20237:00 amRNSFinal Results
12th Jun 20237:00 amRNSNotice of Results & Investor Presentation
27th Apr 20237:00 amRNSShare Incentive Plan
17th Apr 20237:00 amRNSTrading Update
3rd Apr 20237:00 amRNSContract wins/renewals
3rd Feb 202310:46 amRNSDirector/PDMR Shareholding
31st Jan 20237:00 amRNSChange of Auditors
23rd Jan 20234:40 pmRNSSecond Price Monitoring Extn
23rd Jan 20234:35 pmRNSPrice Monitoring Extension
23rd Jan 20232:05 pmRNSSecond Price Monitoring Extn
23rd Jan 20232:00 pmRNSPrice Monitoring Extension
23rd Jan 20237:00 amRNSTrading Update
11th Jan 20232:30 pmRNSDirector/PDMR Shareholding
2nd Dec 20228:45 amRNSDirector/PDMR Shareholding
22nd Nov 20227:00 amRNSHalf-year Report
11th Nov 20227:00 amRNSNotice of Interim Results & Investor Presentation
13th Oct 202210:30 amRNSDirector/PDMR Shareholding
11th Oct 20221:00 pmRNSDirector/PDMR Shareholding
10th Oct 20228:00 amRNSLong Term Incentive Plan
10th Oct 20227:01 amRNSAcquisition of Authlogics Ltd
10th Oct 20227:00 amRNSTrading Update
28th Sep 202212:22 pmRNSResult of AGM
15th Sep 20227:00 amRNSDirector/PDMR Shareholding and Issue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.